Expression of REGγ in atherosclerotic plaques and promotes endothelial cells apoptosis via the cyclophilin A pathway indicates functional implications in atherogenesis

References

• Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519.
   PubMed Web of Science ®Google Scholar
• Rader DJ, Daugherty A. Translating moleculardiscoveries into new therapies for atherosclerosis. Nature. 2008;451(7181):904–913.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.
   PubMed Web of Science ®Google Scholar
• Jin Z-G. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24:1186–1191.
   PubMed Web of Science ®Google Scholar
• Satoh K. Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation. 2008;117:3088–3098.
   PubMed Web of Science ®Google Scholar
• Wang F. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest. 2010;120(11):3979–3995.
   PubMed Web of Science ®Google Scholar
• Bryant SR, Bjercke RJ, Erichsen DA, et al. Vascular remodeling in response to altered blood flow ismediated by fibroblast growth factor-2. Circ Res. 1999;84:323–328.
   PubMed Web of Science ®Google Scholar
• Chiang HY, Korshunov VA, Serour A, et al. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 2009;29:1074–1079.
   PubMed Web of Science ®Google Scholar
• Acevedo L, Yu J, Erdjument-Bromage H, et al. A new role for Nogo as a regulator of vascular remodeling. Nat Med. 2004;10:382–388.
   PubMed Web of Science ®Google Scholar
• Li X, Lonard DM, Jung SY, et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGγ proteasome. Cell. 2006;124(2):381–392.
   PubMed Web of Science ®Google Scholar
• Chen X, Barton LF, Chi Y, et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGγ proteasome. Mol Cell. 2007;26:843–852.
   PubMed Web of Science ®Google Scholar
• Li X, Amazit L, Long W, et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGγamma-proteasome pathway. Mol Cell. 2007;26:831–842.
   PubMed Web of Science ®Google Scholar
• Mao I, Liu J, Li X, et al. REGγ, a proteasome activator and beyond? Cell Mol Life Sci. 2008;65:3971–3980.
   PubMedGoogle Scholar
• Ali A, Wang Z, Fu J, et al. Differential regulation of the REGγ–proteasome pathway by p53/TGF-b signalling and mutant p53 in cancer cells. Nat Commun. 2013;4:2667.
   PubMed Web of Science ®Google Scholar
• Liu J, Yu G, Zhao Y, et al. REGγ modulates p53 activity by regulating its cellularlocalization. J Cell Sci. 2010;123(23):4076–4084.
   PubMed Web of Science ®Google Scholar
• Li L, Dang Y, Zhang J, et al. REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway. Nat Com. 2015;2:6875.
   Google Scholar
• Li L, Dengpan Zhao, Haibin Wei, et al. REGγ deficiency promotes premature aging via the casein kinase 1 pathway. Proc Natl Acad Sci USA. 2013;110:11005–11010.
   PubMed Web of Science ®Google Scholar
• Dong S, Jia C, Zhang S, et al. The REGγamma proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Cell Metab. 2013;18:380–391.
   PubMed Web of Science ®Google Scholar
• Sun L, Fan G, Shan P, et al. Regulation of energy homeostasis by the ubiquitin-independent REGγ proteasome. Nat Com. 2016;7:12497.
   PubMed Web of Science ®Google Scholar
• Liu S, Lai L, Zuo Q, et al. PKA turnover by the REGγamma-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis. J Mol Cell Cardiol. 2014;72:28–38.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Liu S, Zuo Q, et al. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation. Free Radic Biol Med. 2015;82:42–49.
   PubMed Web of Science ®Google Scholar
• Sun J, Luan Y, Xiang D, et al. The 11S proteasome subunit PSME3 is a positive feedforward regulator of NF-κB and important for host defense against bacterial pathogens. Cell Rep. 2016;14(4):737–749.
   PubMed Web of Science ®Google Scholar
• Barton LF, Runnels HA, Schell TD, et al. Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol. 2004;172:3948–3954.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhou L, Ji L, et al. The REGγ-proteasome forms a regulatory circuit with IkBe and NF-kB in experimental colitis. Nat Com. 2016;7:10761.
   PubMed Web of Science ®Google Scholar
• Gao G, Wong J, Zhang J, et al. Proteasome activator REGγ enhances coxsackieviral infection by facilitating p53 degradation. J Virol. 2010;84:11056–11066.
   PubMed Web of Science ®Google Scholar
• Handschumacher. Cyclophilin: a specific cytosolic binding protein for cyclosporine A. Science. 1984;226:544–547.
   PubMed Web of Science ®Google Scholar
• Marks AR. Cellular functions of immunophilins. Physiol Rev. 1996;76:631–649.
   PubMed Web of Science ®Google Scholar
• Jin ZG, Melaragno MG, Liao DF, et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res. 2000;87:789–796.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Jin Z-G, Meoli DF, et al. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res. 2006;98:811–817.
   PubMed Web of Science ®Google Scholar
• Satoh K, Nigro P, Matoba T, et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med. 2009;15:649–656.
   PubMed Web of Science ®Google Scholar
• Liao DF, Jin ZG, Baas AS, et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem. 2000;275:189–196.
   PubMed Web of Science ®Google Scholar
• Pan H, Luo C, Li R, et al. Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2,activation and nuclear translocation of ERK1/2, and chemotactic cell migration. J Biol Chem. 2008;283:623–637.
   PubMed Web of Science ®Google Scholar
• Sherry B, Yarlett N, Strupp A, et al. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci U S A. 1992;89:3511–3515.
   PubMed Web of Science ®Google Scholar
• Xu Q, Leiva MC, Fischkoff SA, et al. Leukocyte chemotactic activity of cyclophilin. J Biol Chem. 1992;267:11968–11971.
   PubMed Web of Science ®Google Scholar
• Allain F, Vanpouille C, Carpentier M, et al. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc Natl Acad Sci USA. 2002;99:2714–2719.
   PubMed Web of Science ®Google Scholar
• Yurchenko V, Zybarth G, O’Connor M, et al. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem. 2002;277:22959–22965.
   PubMed Web of Science ®Google Scholar
• Arora K, Gwinn WM, Bower MA, et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol. 2005;175:517–522.
   PubMed Web of Science ®Google Scholar
• Damsker JM, Bukrinsky MI, Constant SL. Preferential chemotaxis of activated human CD4+T cells by extracellular cyclophilin A. J Leukoc Biol. 2007;82:613–618.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim WJ, Jeon ST, et al. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin Immunol. 2005;116:217–224.
   PubMed Web of Science ®Google Scholar
• Zhu P, Ding J, Zhou J, et al. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res Ther. 2005;7:R1023–R1033.
   PubMed Web of Science ®Google Scholar
• Nigro P. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2010;208(1):53–66.
   PubMed Web of Science ®Google Scholar
• Satoh K, Nigro P, Matoba T, et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med. 2009;15:649–656.
   PubMed Web of Science ®Google Scholar
• Weintraub NL. Understanding abdominal aortic aneurysm. N Engl J Med. 2009;361:1114–1116.
   PubMed Web of Science ®Google Scholar
• Yu P, Wilhelm K, Dubrac A, et al. FGF-dependent metabolic control of vascular development. Nature. 2017;545(7653):224–228.
   PubMed Web of Science ®Google Scholar
• Donato L, Bramanti P, Scimone C, et al. miRNAexpression profile of retinal pigment epithelial cells under oxidative stress conditions. FEBS Open Bio. 2018;8(2):219–233.
   PubMed Web of Science ®Google Scholar
• Donato L, Scimone C, Rinaldi C, et al. Non-coding RNAome of RPE cells under oxidative stress suggests unknown regulative aspects of Retinitis pigmentosa etiopathogenesis. Sci Rep. 2018;8(1):16638.
   PubMedGoogle Scholar
• Donato L, Scimone C, Nicocia G, et al. Role of oxidative stress in Retinitis pigmentosa: new involved pathways by an RNA-Seq analysis. Cell Cycle. 2019;18(1):84–104.
   PubMed Web of Science ®Google Scholar
• Donato L, Scimone C, Rinaldi C, et al. Stargardt phenotype associated with two ELOVL4 promoter variants and ELOVL4 downregulation: new possible perspective to etiopathogenesis? Invest Ophthalmol Vis Sci. 2018;59(2):843–857.
   PubMed Web of Science ®Google Scholar
• Marinucci L, Balloni S, Fettucciari K, et al. Nicotine induces apoptosis in human osteoblasts via a novel mechanism driven by H2O2 and entailing Glyoxalase 1-dependent MG-H1 accumulation leading to TG2-mediated NF-kB desensitization: implication for smokers-related osteoporosis. Free Radic Biol Med. 2018;117:6–17.
   PubMed Web of Science ®Google Scholar
• Donato L, Scimone C, Nicocia G, et al. GLO1 gene polymorphisms and their association with retinitis pigmentosa: a case-control study in a Sicilian population. Mol Biol Rep. 2018;45(5):1349–1355.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theoryversus practice. Circulation. 1999;100:1148–1150.
   PubMed Web of Science ®Google Scholar